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ABSTRACT 
Objective: To enhance the solubility of poorly soluble drugs by using 23 factorial design in the formulation of fast dissolving tablets by employing 
starch oxalate as a superdisintegrant. 
Methods: Starch oxalate was synthesized by gelatinization process. The physical and micromeritic properties were performed to evaluate the 
synthesized starch oxalate. By using 23 factorial design, atenolol fast dissolving tablet was prepared by employing starch oxalate as a 
superdisintegrant in different proportions in each case by direct compression method. In the evaluation of fast dissolving tablets the drug 
content, hardness, friability, disintegration time and other dissolution characteristics were utilized. 
Results: The starch oxalate prepared was found to be fine, free-flowing completely amorphous powder. The compatibility between atenolol and 
starch oxalate were studied and showed no interaction. The drug content, hardness, and friability have been effective with regard to all the 
formulated fast dissolving tablets employing starch oxalate. The optimised formulation F8 has the least disintegration time i.e., 24±0.06s. The In–
vitro wetting time was less (i.e., 28s) in optimized formulation F8. The water absorption ratio of the formulated tablets was found to be more in 
F8 formulation 94.42±0.18%. The cumulative drug dissolved in the optimized formulation F8 was found to be 98.70±0.24% in 5 min.  
Conclusion: The dissolution efficiency of atenolol was enhanced when starch oxalate was found to be a superdisintegrant when combined with 
sodium starch glycolate, crospovidone and, hence to provide immediate release of the formulated fast dissolving tablets contained drug it could 
be used. 
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INTRODUCTION 
Oral administration is the most popular route as it has major 
patient compliance issues and also due to its ease of 
ingestion without pain and versatility. Many patients find it 
difficult to swallow tablets and do not take their medicines 
as prescribed. Particular by pediatrics and geriatrics patients 
this difficulty is experienced, but this problem also covers to 
the patients who are ill in bed or traveling. With 
conventional oral dosage forms many problems are faced by 
groups like mentally ill, developmentally disable and 
patients who are uncooperative. It is estimated that 50% of 
the population is affected by this problem, which results in a 
high incidence of noncompliance and in-effective therapy. In 
the oral cavity, fast dissolving tablets that can dissolve or 
disintegrate have attracted a great deal of attention1. Indeed, 
the fast dissolving tablets are an important and attractive 
alternative to the liquid dosage form. Fast dissolving tablets 
are not only indicated for people having difficulty in 
swallowing but also ideal for unfavorable conditions of 
administration where water is unavailable2. Liquid dosage 
forms are preferred for pediatrics because of their more 
bioavailability when compared to solid dosage forms. But the 
limitation of liquid dosage forms has less stability when 
compared to solid dosage forms3. Fast dissolving tablets are 
unique in nature having both advantages of solid and liquid 
dosage forms like having more bioavailability as liquid 
dosage forms and more stability as solid dosage forms4. The 
aim of the present work was to formulate and characterize a 
novel superdisintegrant i.e starch oxalate in the formulation 
of fast dissolving tablets (FDT) of atenolol by utilizing 
optimization techniques for rapid dissolution of the drug. 
The selection of several experimental and manufacturing 
steps for a given product and to quantitatively select a 
formulation, optimization techniques are used which provide 
both a depth of understanding and an ability to explore and 
determine the ranges for formulation and processing factors. 
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It is at this aspect that optimization can become a useful tool 
to quantitate a formulation that has been qualitatively 
determined. 
The present investigation deals with an attempt of 
systematic formulation approach for optimization of atenolol 
fast dissolving tablets employing starch oxalate, sodium 
starch glycolate, and crospovidone as superdisintegrants. A 
23 factorial design was applied to investigate the main and 
interaction effects of the three formulation variables i.e., 
starch oxalate (A), sodium starch glycolate (B), crospovidone 
(C) in each case to find the formula with less disintegration 
time and more dissolution efficiency in 5 min and to permit 
arbitrary selection of tablets with immediate release of drug 
within 5 min. 
MATERIALS AND METHODS 
Materials 
Potato starch, sodium hydroxide, oxalic acid, mannitol was 
purchased from Finar chemicals Ltd, Ahmedabad. Atenolol, 
sodium starch glycolate, crospovidone was obtained from 
Yarrow chem. Products, Mumbai. Microcrystalline cellulose 
was imported from Qualigens fine chemicals, Mumbai.  
Magnesium stearate and talc was obtained from Molychem, 
Mumbai. 
Preparation of starch oxalate (a novel 
superdisintegrant) 
Initially 5 ml Oxalic acid was dissolved in 20 ml distilled 
water and the pH is adjusted to 3.5 using 1M sodium 
hydroxide or 1M hydrochloric acid. To this 5 parts potato 
starch was added and conditioned for 16 h; the product was 
kept in the oven at 60 ºC for 1 h. Then the product was 
washed with water to remove any unreacted oxalic acid if 
present. After washing, the resultant starch oxalate was kept 
in the oven for 60 ºC until it gets dried. The product obtained 
was ground through sieve no.120. 
Characterization of starch oxalate 
The starch oxalate prepared was evaluated for the following 
Solubility 
Starch oxalate solubility was tested in various solvents like 
distilled water, aqueous buffers of pH 1,2,3,4,6 and organic 
solvents such as alcohol, dichloromethane, chloroform, 
acetone and petroleum ether5. 
pH 
The pH of 1% w/v slurry was measured with a pH meter5. 
Melting point 
Melting point was determined by using melting point 
apparatus5. 
Viscosity 
The viscosity of 1% dispersion in water was measured using 
Ostwald’s viscometer5. 
Swelling index 
Starch oxalate (200 mg) was added to two different 
graduated test tubes containing 10 ml water and light liquid 
paraffin and mixed. Then the dispersed solution in the tubes 
was allowed to stand for 12 h. The volumes of the residue in 
the tubes were noted. The swelling index ) of the 
material was calculated as follows6. 
Test for gelling property 
The evaluation of the gelling property (gelatinization) of the 
prepared starch oxalate and starch was done by heating a 
7% w/v dispersion of each in water at 100  ºC for 30 min7. 
Moisture absorption 
The hygroscopic nature of starch oxalate was evaluated by 
moisture absorption studies in a closed desecrator at 86% 
relative humidity and at room temperature7. 
Particle size 
Particle size analysis was determined by sieving using 
standard sieves7. 
Density 
Density (g/cc) was determined by liquid displacement 
method using distilled water as liquid7. 
Bulk density 
Both loose bulk density (LBD) and tapped bulk density 
(TBD) were determined by transferring the proper weighed 
amount of sample in 50 ml measuring cylinder, the granules  
of without any agglomerates were taken and measured the 
volume of packing and tapped 50 times on a plane surface 
and tapped volume of packing recorded LBD and TBD 
calculated by following formula[7]. 
 
 
Percentage compressibility index 
Percentage compressibility of the powder mix was calculated 
by Carr’s compressibility index by using the following 
formula 8. 
 
Where Final= Tapped bulk density; Initial= Loose bulk 
density. 
Angle of repose 
The angle of repose was done by the fixed funnel method. 
The frictional forces in loose powder or granules can be 
determined by the angle of repose. This is the maximum 
angle possible between the surface of a mass of powder or 
granules along with the horizontal plane. The angle of repose 
is calculated by using the following equation8; 
 
                     
Where θ=angle of repose; h=height of the pile; r=radius of 
the pile. 
Fourier transform infrared (FTIR) spectroscopy 
FTIR spectra of starch oxalate were recorded on samples 
prepared in potassium bromide (KBr) disks using a Bruker 
FT-IR, (Tokyo, Japan). In (KBr) disks the Samples were 
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prepared by means of a hydrostatic press at 6-8 tons 
pressure. The scanning range was 500 to 4000cm-18. 
X-ray diffraction 
The diffraction pattern of starch oxalate was recorded with 
an X-ray diffractometer (analytical spectra’s Pvt. Ltd., 
Singapore). X-ray diffraction was worked at room 
temperature (30 ºC) with a diffractometer; target, Cu(λ=1.54 
Aº), filter, Ni, voltage, 45 kV, current 40 mA; time constant 
10mm/s; scanning rate 2 º/min; measured from 10-35 º at 
full scale 2008. 
Drug–excipient compatibility studies 
The compatibility of starch oxalate with the selected drug 
(atenolol) was evaluated in DSC and FTIR studies. 
Differential scanning calorimetry (DSC) 
 In Perkin Elmer thermal analyser the samples (2- 5 mg) of 
atenolol and their mixtures (1: 1) with starch oxalate were 
sealed into aluminum pans and scanned at a heating rate of 
10 0C min-1 over a temperature range 30 – 350 0C and was 
recorded to get DSC thermograms8. 
Infrared Spectroscopy 
Fourier transform infra red (FTIR) spectra of atenolol, and 
their mixtures (1: 1) with starch oxalate were recorded on a 
Perkin Elmer, IR Spectrophotometer model: Spectrum RXI, 
using KBr disc as a reference 8. 
Preparation of atenolol fast dissolving tablets  
The tablets were prepared by direct compression method 
employing 23 factorial design in which three independent 
variables {superdisintegrants i.e., starch oxalate (A), sodium 
starch glycolate (B), crospovidone (C)} and one dependent 
variable (dissolution efficiency in 5 min) were preferred. The 
composition of a different formulation of atenolol fast 
dissolving tablets is shown in table no 1 in which the levels 
of superdisintegrants were selected at 2 levels i.e., lower and 
higher level concentrations. For starch oxalate (A), sodium 
starch glycolate (B) and crospovidone (C), the lower level is 
zero concentration and higher level i.e., 5% concentration. 
For uniformity in particle size, each ingredient was passed 
through # 100 mesh sized screen to get fine particles before 
mixing. All the excipients namely starch oxalate, sodium 
starch glycolate, crospovidone, mannitol, and 
microcrystalline cellulose were geometrically weighed and 
mixed by trituration to which atenolol was added. Finally, 
talc and magnesium stearate were administered in the 
powder mixture. Finally, the mixed blend was compressed 
by utilizing eight station rotator press Karnawathi 
Machineries Pvt, Ltd., Ahmedabad, India). 
 
Table 1: Formulation of atenolol fast dissolving tablets employing starch oxalate prepared by direct compression 
method. 
Ingredients(mg/tablet) F1 F2 F3 F4 F5 F6 F7 F8 
Atenolol 50 50 50 50 50 50 50 50 
Starch oxalate - 11 - 11 - 11 - 11 
Sodium starch glycolate - - 11 11 - 11 - 11 
Crospovidone - - - - 11 - 11 11 
Mannitol 61.2 50.2 50.2 39.2 50.2 39.2 39.2 28.2 
Microcrystalline cellulose 100 100 100 100 100 100 100 100 
Talc 4.4 4.4 4.4 4.4 4.4 4.4 4.4 4.4 
Magnesium sterate 4.4 4.4 4.4 4.4 4.4 4.4 4.4 4.4 
Total weight (mg) 220 220 220 220 220 220 220 220 
 
Evaluation of atenolol fast dissolving tablets 
Hardness 
To break a tablet diametrically the compression force, the 
force of the tablet hardness is required. The hardness tester 
used in the study was Monsanto hardness tester, which 
applies force to the tablet diametrically with the help of an 
in-built spring and expressed in kg/cm29. 
Uniformity of weight 
Weight variation test was done with 20 tablets. It is the 
individual variation of tablet weight from the average weight 
of 20 tablets9. 
Average weight of tablet % Deviation 
 80 mg or less ±10 
More than 80 mg or less than 
125mg 
±7.5 
125 mg or less ±5 
 
Friability 
The friability of tablets was determined by using a Roche 
friabilator. Initially, 20 tablets were weighed and the tablets 
were kept in Roche friabilator and it was rotated at 25 rpm 
for 4 min or up to 100 revolutions. After 4 min or 100 
revolutions, the tablets were taken out from the friabilator 
and then reweighed after removal of fines. Finally, the 
percentage of weight loss was calculated10. 
F  
Other W (initial) = Initial weight of tablet. 
          W (final) = Final weight of tablet. 
Drug Content Uniformity 
For content uniformity, ten tablets were weighed and 
powdered a quantity of powder equivalent to 10 mg of 
atenolol was extracted into 0.1N HCl buffer and filtered. The 
atenolol content was determined by measuring the 
absorbance spectrophotometrically at 225 nm after 
appropriate dilution with 0.1N HCl buffer. The drug content 
was determined as an average of three determinations 10. 
Wetting Time 
The wetting time of tablets was determined by using a very 
simple procedure. Five circular tissue papers of 10 cm 
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diameter were kept on a petri dish with a 10 cm diameter. 
Ten milliliters of distilled water containing a water-soluble 
dye (amaranth) was added to the petri dish. A tablet was 
gently placed on the tissue paper. The time required for 
water to reach the upper surface of the tablet was noted as 
wetting time 10. 
Water Absorption Ratio 
In a small petri dish a piece of tissue paper was folded twice 
and kept according to its size containing 6 ml of water and to 
that, The tablet was weighed and kept on the tissue paper 
and was allowed to wet completely. Then the wetted tablet 
was weighed. Water absorption ration R was calculated 
using the following equation 11. 
 
Where, 
W1 = weight of tablet after water absorption. 
W2 = weight of tablet before water absorption. 
In – vitro Disintegration Time 
Disintegration time for FDTs was measured by using USP 
disintegration apparatus 0.1N HCl buffer. The volume of 
medium was 900 ml and the temperature was 37±0.2 ºC. The 
time in seconds was measured for complete disintegration of 
the tablet with no palatable mass remaining in the 
apparatus12. 
In – vitro Dissolution Rate Studies 
The in – vitro dissolution rate study of atenolol fast 
dissolving tablets were performed using 8 stage dissolution 
test apparatus (Electrolab TDT=08L) fitted with paddles (50 
rpm) at 37±0.5 ºC, using 0.1N HCl buffer (900 ml) as a 
dissolution media. At the predetermined time intervals, 5ml 
samples were withdrawn, filtered through a 0.45µ 
membrane filter, diluted and assayed at 225 nm using an 
ELICO UV/Visible spectrophotometer model - 371. 
Cumulative percentage release was determined by using 
standard absorbance from the calibration curve. All the 
dissolution experiments were administered in triplicate 
(n=3) 13. 
RESULTS AND DISCUSSION 
The starch oxalate prepared was found to be fine, free-
flowing amorphous powder. The physical and micromeritics 
properties of the starch oxalate are summarized in table 2. It 
was insoluble in aqueous solvents and insoluble in organic 
solvents tested (methanol, petroleum ether, 
dichloromethane, and chloroform) the pH of 1% aqueous 
dispersion was 5.61. 
Starch oxalate exhibited good swelling in water. The swelling 
index was found to be 66.66 % indicating that it is suitable 
for superdisintegrant. All micrometric properties had shown 
good flow properties needed manufacturing of tablets. The 
density of starch oxalate was found to be 1.1792 g/ml. The 
angle of repose and compressibility index showed good flow 
properties of starch oxalate. The FTIR spectrum of potato 
starch and starch oxalate is shown in fig: 1 and 2. The 
presence of peak absorption at 1637.30 cm-1 in FTIR 
characteristic peak of ester concluded that starch oxalate 
(ester) was formed when starch was allowed to react with 
oxalic acid. The X-ray diffraction pattern (fig: 3) of starch 
oxalate showed no characteristic peaks, which indicates that 
the structure is completely amorphous. As the starch oxalate 
was completely amorphous powder and it had got all the 
characteristic of superdisintegrants it was concluded that 
starch oxalate can be used as novel superdisintegrant in the 
formulation of fast dissolving tablets. 
 
Table 2: Physical and micromeritics properties of the starch oxalate prepared 
Parameters Observation 
Solubility Insoluble in all aqueous and organic solvents tested. 
pH (1% w/v aqueous dispersion) 5.61±0.02 
Melting point (in ºC) 232±0.001 
Viscosity(1%w/v aqueous dispersion)(in 
cps) 
1.0242±0.008 
Swelling index (in %) 66.66 ±0.05 
Gelling property No gelling and the swollen particles of starch oxalate separated from water. 
Whereas in the case of starch, it was gelatinized and formed a gel.  
Moisture absorption (in %) 4.8±0.2 
Particle size (in µm) 135±0.09 
Density (in g/cc) 1.1792 ±0.0004 
Bulk density (in g/cc) 0.61 ±0.03 
Angle of repose (in º ) 26.49±0.07 
Compressibility index (in %) 35.59±0.01 
*SD Standard Deviation from mean, n=3, mean±SD 
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Figure 1: Fourier transform infrared spectra of potato starch. 
 
Figure 2: Fourier transform infrared spectra of starch oxalate 
 
Figure 3: X-ray diffraction pattern of starch oxalate 
The compatibility of starch oxalate with the selected drug 
(atenolol) was evaluated by DSC, FTIR studies. The DSC 
thermograms of atenolol and atenolol – starch oxalate are 
shown in fig.4 and 5. The DSC thermograms of atenolol and 
atenolol – starch oxalate exhibited exothermic peaks at 
155.66 ˚C and 152.63 ˚C respectively. These melting peaks of 
atenolol and atenolol – starch oxalate are nearer to the 
melting points of atenolol (158-160 ˚C). The peaks observed 
in the DSC thermograms of atenolol and atenolol – starch 
oxalate mixtures correspond to the melting points of the 
respective drug indicating no interactions between the 
selected drug and starch oxalate polymer. Thus, the DSC 
study of starch oxalate and selected drug indicated no 
interaction between them. 
The FTIR spectra of atenolol and atenolol - starch oxalate are 
shown in figs. 6 and 7. The characteristic FTIR bands of 
atenolol at 1637.41 cm-1 (C=O Stretched, N-H Bending), 
1583.60 cm-1 (C-C aromatic ring)1417.66 cm-1 (O-H Bending) 
and atenolol - starch oxalate at 1637.47 cm-1 (C=O Stretched, 
N-H Bending), 1583.74 cm-1 (C-C aromatic ring)1416.35 cm-1 
(O-H Bending) was all observed in the FTIR spectra of both 
atenolol and atenolol - starch oxalate. These FTIR spectral 
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observations also indicated no interaction between starch 
oxalate and the drug selected. 
Thus, the results of DSC and FTIR indicated no interaction 
between the selected drug and starch oxalate, the new 
superdisintegrant. Hence, starch oxalate could be used as a 
superdisintegrant in the design of fast dissolving tablets of 
the selected drug.  
  
 
Figure 4: DSC Thermogram of atenolol pure drug 
 
 
Figure 5:  DSC Thermogram of atenolol with starch oxalate 
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Figure 6: FTIR Spectra of Atenolol Pure Drug 
 
Figure 7:  FTIR spectra of atenolol with starch oxalate 
Evaluation of tablets 
Hardness 
The hardness of tablets from all batches was found to be in 
the range of 3.6±0.03 kg/cm2 to 4±0.01 kg/cm2. All tablets 
were found to be hard enough so that they could easily 
withstand the handling and storage conditions. 
Friability 
All the tablets shown acceptable friability as none of the 
tested batches showed percentage friability that exceeded 
1%. The percent friability of all batches found in the range of 
0.12%-0.17% indicating the good mechanical resistance of 
tablets. Hence, it was observed that tablets could withstand 
the pressure, mechanical shocks during handling, 
transportation, storage, and manufacturing processes. 
Drug content 
Drug content of all the formulation batches was found to be 
between 47.65±0.55 to 49.95±0.66 mg/tablet. Hence, it can 
be concluded that all the formulations are having an accurate 
amount of drug distributed uniformly in powder mass and 
are within acceptable limits as per IP 14.  
Disintegration studies 
In vitro disintegration time was determined by the USP 
dissolution apparatus. The disintegration rate has a 
correlation with water absorption capacity of the tablet and 
the In vitro disintegration time was found between 24±06 to 
156±04s. The outcomes were arranged in tabulated form 
and data was demonstrated in table 3.  
 
Table 3: Physical properties: Hardness, Friability, Drug content of atenolol fast dissolving tablets prepared by the direct 
compression method 
Formulation Hardness 
(Kg/Cm2) n±S.D 
Friability 
(%)n±S.D 
Drug content 
(mg/tab)n±S.D 
Disintegration 
Time(sec)n±S.D 
Water absorption 
ratio(%)n±S.D 
F1 3.9 ±  0.02 0.13 ±  0.014 48.24 ±  0.17  156 ± 0.04   56.34 ± 0.13  
F2 3.8 ±  0.04  0.12 ±  0.013  47.88 ±  0.43  139 ± 0.03  64.61 ± 0.14  
F3 3.7 ±  0.03  0.16 ±  0.012  47.69 ±  0.18  121 ± 0.02  65.22 ± 0.17  
F4 3.6±  0.06  0.13 ±  0.014  48.82 ±  0.56  49  ± 0.04  79.29 ± 0.28  
F5 4.0 ±  0.01  0.12 ±  0.013  47.65 ±  0.55  54  ± 0.07  75.26 ± 0.43  
F6 3.8 ±  0.05  0.15 ±  0.012  48.66 ±  0.58  35  ± 0.09  79.29 ± 0.28  
F7 3.7 ±  0.03  0.17 ± 0.014  49.02 ±  0.67  40  ± 0.08  88.82 ± 0.29  
F8 3.9 ±  0.05  0.15 ±  0.012  49. 95±  0.66  24  ± 0.06  94.42 ± 0.18  
*SD Standard Deviation from mean, n=3, mean±SD 
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All the formulations showed disintegration time of less than 
180s. It was found that the formulation of F8 showed least 
disintegration time i.e., 24s as compared to other 
formulations. The order for a disintegration time in atenolol 
fast dissolving tablets was found to be 
F8<F6<F7<F4<F5<F3<F2<F1. The order of disintegration 
time may be due to the interaction and main effects of the 
super disintegrants used in the formulation of fast dissolving 
tablets. 
 
Water absorption ratio and wetting time 
The Water absorption ratio was found to be in between 
56.34±0.13 to 94.42±0.18. This increased behavior due to 
the water taking the ability of super disintegrants. The 
wetting time was found to be in between 28±0.41 to 
144±0.21s. The outcomes were tabulated and data 
demonstrated in Table 3 and fig. 8 and 8a. It was found that 
the formulation F8 containing 5% starch oxalate, sodium 
starch glycolate 5% and crospovidone 5% showed less 
wetting time i.e. 28±0.41s as compared to other 
formulations.
 
                                                    
F1 of atenolol fast dissolving tablet                                                 F2 of atenolol fast dissolving tablet 
At Time=0sec                    At Time=144 sec                                     At Time=0 sec                        At Time=139 sec 
 
                                        
                       At Time=0 sec                   At Time=116 sec                               At Time=0 sec                        At Time=67 sec  
                          F3 of atenolol fast dissolving tablet                                                     F4 of atenolol fast dissolving tablet 
Figure 8: Wetting time of atenolol fast dissolving tablets prepared employing starch oxalate 
 
                            
                    At Time=0 sec                        At Time=83 sec                                             At Time=0 sec                       At Time=55 sec    
            F5 of atenolol fast dissolving tablet                                    F6 of atenolol fast dissolving tablet 
 
                                                  
                   At Time=0  sec                       At Time=43sec                                    At Time=0 sec                         At Time=28 sec    
                        F7 of atenolol fast dissolving tablet                                                       F8 of atenolol fast dissolving tablet 
Fig. 8a: Wetting time of atenolol fast dissolving tablets prepared employing starch oxalate 
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In vitro dissolution studies 
Dissolution rate depends on the wetting time of the 
disintegrant, among all the formulations F8 has less wetting 
time and has greater dissolution rate and then this is the 
other conformance test for correct selection of desirable. In 
vitro dissolution studies of all the formulation were done and 
depicted in fig. 9 (F1 to F4) and fig. 9a (F4 to F8).  In all 
formulations F8 formulation was selected as the promising 
formulation containing 5% starch oxalate, 5% sodium starch 
glycolate   and 5% crospovidone with 98.70% release in 5 
min which may be due to the interaction effect between the 
three super disintegrants i.e., starch oxalate, Sodium starch 
glycolate and crospovidone at a concentration of 5% each. 
The dissolution parameters of the formulation from (F1–F8) 
which were made by direct compression method were 
shown in the table: 4. In all these cases the PD5 (percent 
dissolved in 5 min) was more in F8 which consists of 5% 
starch oxalate, 5% sodium starch glycolate and 5% 
crospovidone. The same was in the case of DE5 % 
(dissolution efficiency in 5 min). The PD5 & DE5 % revels that 
starch oxalate was effective at 5% along with, 5% sodium 
starch glycolate and 5% crospovidone when the 
formulations were made by direct compression using these 
superdisintegrants. The K1 decreased in all the formulation 
when compared to the F8 formulation which was given in 
the table 4. The number of folds increases in DE5% and the 
number of folds increases in K1 (min -1) were given in the 
table 4.  From the results, it was concluded that starch 
oxalate could be used as a super disintegrant in the 
formulation of fast dissolving tablets of atenolol. To evaluate 
the individual and combined effects of the three factors 
involved, fast dissolving tablets were formulated employing 
selected combinations of the factors as per 23-factorial 
design.
  
Table 4: Dissolution parameters of atenolol fast dissolving tablets formulated employing starch oxalate and other 
known super disintegrants prepared by direct compression method. 
Paramters F1 F2 F3 F4 F5 F6 F7 F8 
PD5 36.23±0.39 41.00±0.41 43.86±0.27 58.17±0.86 51.97±0.14 61.03±0.66 80.58±0.92 98.70±0.11 
DE5 (%) 17.8±0.54 20.5±0.29 24.1±0.61 27.9±0.45 29.4±0.09 30.8±0.39 50.9±0.87 60.2±0.54 
Increase in DE5 
(%) No of Folds 
- 1.151 1.353 1.567 1.651 1.730 2.859 3.382 
K (min-1) 0.070±0.003 0.039±0.007 0.082±0.005 0.135±0.001 0.103±0.007 0.159±0.004 0.308±0.002 0.552±0.009 
Increase in K 
(min-1) No of 
Folds 
- 0.565 1.174 1.924 1.467 2.260 4.371 7.828 
 *SD Standard Deviation from mean, n=3, mean±SD, PD5-Percent dissolved in 5 min., DE5%-Dissolution efficiency in 5 min., 
K1 =First order rate constant 
 
 
 
Figure 9:  Dissolution profiles of atenolol fast dissolving tablets prepared employing starch oxalate (F1-F4) (n=3, 
mean±SD) 
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Figure 9a: Dissolution profiles of atenolol fast dissolving tablets prepared employing starch oxalate (F5-F8) (n=3, 
mean±SD) 
 
The fast dissolving tablets parameters like disintegration 
time and dissolution efficiency in 5min were analyzed as per 
ANOVA of 23-factorial design. ANOVA of fast disintegrating 
times (Table 5) indicated that the individual effects of starch 
oxalate (A), sodium starch glycolate (B) and crospovidone 
(C), as well as the combined effects of AB, AC, BC and ABC 
factors, were significant (P<0.05) on disintegration time and 
dissolution efficiency in 5 min of atenolol fast dissolving 
tablets.  
ANOVA of dissolution efficiency in 5 min (Table 6) indicated 
that the individual effects, as well as combined effects of the 
three factors (i.e., starch oxalate, sodium starch glycolate, 
and crospovidone), were all significant (p<0.05). The ANOVA 
results thus indicated that the three factors have a significant 
influence on the disintegration time and dissolution 
efficiency in 5 min of atenolol fast dissolving tablets. 
   
Table 5: ANOVA of disintegrating times of atenolol fast dissolving tablets employing starch oxalate 
Source of variation d.f S.S M.S.S Variance ratio Result 
Replicates 2 200.0833 100.0416 3.9573 P >0.05 
Treatments 7 62268.9583 8895.5654 351.8857 P < 0.05 
Starch oxalate(A) 1 6240.375 6240.375 246.8532 P < 0.05 
Sodium starch glycolate (B) 1 1208.375 1208.375 47.8002 P < 0.05 
Starch oxalate X  Sodium starch glycolate 
(AB) 
1 1190.0416 1190.0416 47.0779 P < 0.05 
Crospovidone (C) 1 37209.375 37209.375 1471.9073 P < 0.05 
Starch oxalate X Crospovidone (AC) 1 1276.0416 1276.0416 50.4769 P < 0.05 
Sodium starch glycolate  X Crospovidone 
(BC) 
1 4845.0416 4845.0416 191.6574 P < 0.05 
Starch oxalate X Sodium starch glycolate X 
Crospovidone(ABC) 
1 1162.0416 1162.0416 45.9673 P < 0.05 
Error 14 353.9167 25.2797 - - 
Total 23 - - - - 
P < 0.05 indicate significance; p > 0.05 indicate non-significance*S.S= Sum of Squares, *M.S.S= Mean Sum of Square, *d.f= Degrees of Freedom 
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Table 6: ANOVA of dissolution efficiency in 5 min of fast dissolving tablets formulated employing starch oxalate 
Source of variation d.f S.S M.S.S Variance ratio Result 
Replicates 2 134.2406 67.1203 3.5451 P > 0.05 
Treatments 7 4814.9833 687.8547 36.3306 P < 0.05 
Starch oxalate(A) 1 255.4537 255.4537 13.4923 P < 0.05 
Sodium starch glycolate (B) 1 1480.5104 1480.5104 78.1965 P < 0.05 
Starch oxalate X  Sodium starch glycolate 
(AB) 
1 180.442 180.442 9.5304 P < 0.05 
Crospovidone (C) 1 2703.0037 2703.0037 142.7652 P < 0.05 
Starch oxalate X Crospovidone (AC) 1 325.678 325.678 17.1656 P <0.05 
Sodium starch glycolate  X crospovidone (BC) 1 372.0937 372.0937 19.6529 P < 0.05 
Starch oxalate X Sodium starch glycolate X 
Crospovidone(ABC) 
1 223.678 223.678 11.8140 P < 0.05 
Error 14 265.0655 18.9332 - - 
Total 23 - - - - 
P < 0.05 indicate significance; p > 0.05 indicate non-significance, *d.f= Degrees of Freedom *S.S= Sum of Squares, *M.S.S= Mean 
Sum of Squares 
 
Fast dissolving tablets formulated employing starch oxalate 
(5%), sodium starch glycolate (5%) and crospovidone (5%) 
as super disintegrants exhibited less disintegration time and 
more dissolution efficiency in 5 min. Formulation F8 gave 
release of 98.70% in 5 min fulfilling the official specification, 
based on disintegration time and dissolution efficiency in 5 
min, formulation F8 is considered as a good fast dissolving 
tablet formulations of atenolol which was found to better 
than the atenolol fast dissolving tablets formulated by 
Parthiban S. et al.. 15. 
CONCLUSION 
Starch oxalate is an efficient superdisintegrant for fast 
dissolving tablets. The less disintegration time and 
dissolution efficiency in 5min of the fast dissolving tablets of 
atenolol depended on the concentration of superdisintegrant 
employed i.e., starch oxalate (5%), sodium starch glycolate 
(5%), and crospovidone (5%). The formulated fast dissolving 
tablets of atenolol employing starch oxalate, sodium starch 
glycolate and crospovidone exhibited good dissolution 
efficiency in 5 min which can be used for the fast therapeutic 
action of atenolol.   
Overall, Starch oxalate was found to be a super-disintegrant 
when combined with sodium starch glycolate and 
crospovidone, the dissolution efficiency of atenolol was 
enhanced and hence it could be used in the formulation of 
fast dissolving tablets to provide immediate release of the 
poorly soluble drugs within 5 min. 
Abbreviations: 
FTIR - Fourier transform infrared spectra  
DSC - Differential scanning calorimetry 
ANOVA – Analysis of variance  
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